Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Diseases of the Thyroid

  Free Subscription


Articles published in Mod Pathol

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    December 2021
  1. SABURI S, Tsujikawa T, Miyagawa-Hayashino A, Mitsuda J, et al
    Spatially resolved immune microenvironmental profiling for follicular thyroid carcinoma with minimal capsular invasion.
    Mod Pathol. 2021 Dec 24. pii: 10.1038/s41379-021-00993.
    PubMed     Abstract available


    September 2021
  2. PARK H, Shin HC, Yang H, Heo J, et al
    Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations.
    Mod Pathol. 2021 Sep 8. pii: 10.1038/s41379-021-00907.
    PubMed     Abstract available


    July 2021
  3. SUSTER D, Michal M, Suster S
    Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component".
    Mod Pathol. 2021 Jul 27. pii: 10.1038/s41379-021-00876.
    PubMed    


    June 2021
  4. AL-OBAIDY KI, Bridge JA, Cheng L, Sumegi J, et al
    EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma.
    Mod Pathol. 2021 Jun 7. pii: 10.1038/s41379-021-00833.
    PubMed     Abstract available


    April 2021
  5. ROUKAIN A, Sykiotis GP
    CTNNB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component.
    Mod Pathol. 2021 Apr 12. pii: 10.1038/s41379-021-00809.
    PubMed    


    December 2020
  6. DOLEZAL JM, Trzcinska A, Liao CY, Kochanny S, et al
    Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
    Mod Pathol. 2020 Dec 10. pii: 10.1038/s41379-020-00724.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: